Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3.
Figure 3.

Prediction of gene predisposition and resistance to hypermethylation in cancer. (A) SINE and LINE scores of the training set genes. The scores were calculated according to the described log-odds ratio method for each gene and are represented as horizontal bars (white bars, SINE score; black bars, LINE score). Methylation status determined by bisulfite PCR methods is shown on the right. Genes with concordant depletion of SINE and LINE retrotransposons (log-odds ≥ 0) were predominantly methylation-prone, with the opposite found for genes with enrichment of both SINE and LINE repeats. Discordant SINE and LINE scores likely represent a class of genes with intermediate predisposition to methylation. *Transcript variant coding for the P16INK4A protein. **Transcript variant coding for the P14ARF protein. Black rectangles represent methylated genes; white rectangles represent unmethylated genes. (B) The predictive method based on SINE and LINE retrotransposons abundance was applied to a test set composed of 142 genes. The frequency of genes correctly classified according to their DNA methylation status in cancer was 79% for methylation-resistant and 75% for methylation-prone genes. These values were closely related to those found in the training set (gray bars). (C) Validation of the predictive method in a large set of cancer cell lines and primary cancer tissues. Methylation status of more than 6600 autosomal gene promoters was determined by MCAM. X chromosome genes were excluded from this analysis due to their hemimethylated status in female samples. The measured DNA methylation per tissue type was significantly higher in predicted methylation-prone genes than in predicted methylation-resistant and methylation-intermediate genes. Methylation is presented as the log2 ratio (cancer/control) of all oligonucleotide probes of a predicted methylation status.

This Article

  1. Genome Res. 20: 1369-1382

Preprint Server